BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2022 8:46:13 AM | Browse: 146 | Download: 353
 |
Received |
|
2021-09-27 13:31 |
|
Peer-Review Started |
|
2021-09-27 13:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-04 19:47 |
|
Revised |
|
2021-12-17 14:47 |
|
Second Decision |
|
2022-03-18 06:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-03-26 21:54 |
|
Articles in Press |
|
2022-03-26 21:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-03-13 11:14 |
|
Typeset the Manuscript |
|
2022-04-08 09:29 |
|
Publish the Manuscript Online |
|
2022-05-13 08:46 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Marc Huguenot, Anne-Catherine Bruhm and Manfred Essig |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marc Huguenot, MD, Chief Physician, Gastroenterology and internal medicine, Tiefenau Hospital, Tiefenaustrasse 112, Bern 3004, Switzerland. marc.huguenot@gmail.com |
| Key Words |
Eosinophilic esophagitis; Benralizumab, Eosinophilic asthma; Case report |
| Core Tip |
Born in 1965, our patient developed the first symptoms of dyspepsia and food impaction at the age of 28. Eosinophilic esophagitis was diagnosed 19 years later in 2012. The first treatment began in 2013 with oral topical glucocorticoids. With concomitant therapy-resistant asthma, treatment with mepolizumab was initiated in addition to standard asthma therapy in 2016. Because of again suboptimal control of asthma, therapy was switched to benralizumab in 2019. In subsequent gastroscopies, histological remission was observed, but our patient reported pain in the esophagus and further food impaction. This case harbors typical aspects of the complexity of treating eosinophilic esophagitis. |
| Publish Date |
2022-05-13 08:46 |
| Citation |
Huguenot M, Bruhm AC, Essig M. Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report. World J Clin Cases 2022; 10(14): 4502-4508 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i14/4502.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i14.4502 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
